$202 Million is the total value of Iguana Healthcare Management, LLC's 69 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | $8,204,000 | +12.2% | 50,000 | 0.0% | 4.06% | -7.1% | |
| WBA | WALGREENS BOOTS ALLIANCE INC | $2,907,000 | +0.3% | 35,000 | 0.0% | 1.44% | -17.0% | |
| WALGREENS BOOTS ALLIANCE INCcall | $2,076,000 | +0.3% | 25,000 | 0.0% | 1.03% | -17.0% | ||
| GILD | GILEAD SCIENCES INC | $1,698,000 | -5.1% | 25,000 | 0.0% | 0.84% | -21.5% | |
| AZN | ASTRAZENECA PLCsponsored adr | $1,557,000 | +14.0% | 50,000 | 0.0% | 0.77% | -5.6% | |
| RARX | RA PHARMACEUTICALS INC | $1,065,000 | +40.1% | 50,000 | 0.0% | 0.53% | +16.1% | |
| ADMA | ADMA BIOLOGICS INC | $488,000 | -4.7% | 100,000 | 0.0% | 0.24% | -21.2% | |
| ONCOMED PHARMACEUTICALS INCcall | $461,000 | +19.4% | 50,000 | 0.0% | 0.23% | -1.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.